Register entry
Meiji Seika Pharma Co., Ltd.
- Registered sites
- 3
- Drug products
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacturePackaging
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Meiji Seika Pharma Co., Ltd. | KitakamiJapan | Analytical testing, Active ingredient (API) manufacture | 3002902776 |
| Meiji Seika Pharma Co., Ltd. | Motosu-gunJapan | Analytical testing, Active ingredient (API) manufacture | 3008927877 |
| Meiji Seika Pharmatech Co., Ltd. | OdawaraJapan | Analytical testing, Finished drug manufacture, Packaging | 3015407855 |
Catalogue
Marketed products
1Showing 1 of 1.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Doxorubicin | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.